Health Moderna vaccine candidate could provide longer-term immunity - Goldman leaves Moderna on 'Buy'

12:10  04 december  2020
12:10  04 december  2020 Source:   finanzen.net

What are the side-effects of Moderna's, Pfizer's vaccines? Your questions answered

  What are the side-effects of Moderna's, Pfizer's vaccines? Your questions answered Moderna's and Pfizer/BioNTech's annoucements of promising results for their vaccines against COVID-19 have prompted questions from CBC readers. What are the side-effects? How long does the protection last? How were volunteers infected? When will Canadians get this vaccine? Here are the answers.Moderna announced on Nov. 16 that preliminary data from its ongoing Phase 3 clinical trial shows the vaccine is 94.5 per cent effective at preventing COVID-19 caused by the coronavirus.

Long - Term Safety. The Pfizer and Moderna vaccines far exceeded the Food and Drug Administration’s requirement that coronavirus vaccines be at Moderna also reported on Monday that its vaccine had a longer shelf life under refrigeration and at room temperature than previously

Moderna Daily. “The danger for investors lies in conflating the importance of these drugs in fighting the pandemic with the attractiveness of the long - term business One danger that could hurt these front-runners in the race for a vaccine is that there are many vaccines that are close to the final stage of

US pharmaceutical company Moderna has announced that its COVID-19 vaccine has the potential to provide longer-term immunity.

DANIEL ROLAND/AFP/Getty Images © Provided by Finances.net DANIEL ROLAND / AFP / Getty Images

The company expects to be able to produce 20 million doses of the vaccine candidate in the US by the end of this year.

According to the National Institute of Allergy and Infectious Diseases, participants in a previous clinical vaccine study still had "high levels of neutralizing antibodies" three months after their first vaccination - or two months after their second vaccination. The study said the vaccine had "the potential to provide lasting" immunity. No serious adverse effects occurred after the two months.

15 Worst Foods Foods for Your Health

  15 Worst Foods Foods for Your Health If you have diabetes, heart disease, or high blood pressure, steer clear of these menu items. They're some of the worst fast foods for your health.

3, 2020-- Moderna , Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new “These interim Phase 1 data suggests that mRNA-1273, our COVID-19 vaccine candidate can generate durable neutralizing antibodies across

Moderna said it was working with manufacturing partners like Lonza Group AG of Switzerland and Laboratorios Farmacéuticos Moderna , which is one of the handful of companies with vaccine candidates in late-stage testing, also said it was on track to complete enrollment of about 30

"These preliminary Phase 1 data suggest that mRNA-1273, our vaccine candidate for COVID-19, can produce permanent neutralizing antibodies in all age groups, including older and older adults," told Moderna .

In the first quarter of next year, between 100 and 125 million doses of the vaccine candidate are expected to be available worldwide, including 85 to 100 million doses in the United States.

Goldman leaves Moderna at 'Buy' target of $ 139

The US investment bank Goldman Sachs has left the rating for Moderna at "Buy" with a price target of 139 US dollars. The vaccine developer has confirmed the production capacity for the COVID-19 vaccine, wrote analyst Salveen Richter in a study published on Friday. The expert adapted her sales estimates to the most recent vaccine supply contract with Great Britain.

Publication of the original study: 03.12.2020 / 22:38 / GMT First distribution of the original study: date not specified in study / time not specified in study / time zone not specified in study (Dow Jones / dpa-AFX)

FDA Endorses Moderna COVID Vaccine for Approval, Fauci Says He Expects Distribution 'Very Soon' .
Dr. Anthony Fauci said he anticipates seeing "shots in the arm by the very early part of next week"A panel of FDA advisers recommended, in a 20-0 vote with one abstention, that the FDA move forward and authorize the Moderna vaccine for emergency use, The New York Times reported.

usr: 0
This is interesting!